longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

EPAC

EPAC
35.2200.51%( -0.180 )

LongbridgeAI

Enerpac Tool Group Reports Q3 Fiscal 2026: Revenue $167.6M, Net Income $29.8M, Adjusted EPS $0.60

TradingView
Jul 8, 2026 at 12:33 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Enerpac Tool Group reported Q3 fiscal 2026 net sales of $167.6M, up 6% year-over-year, with net income of $29.8M and adjusted EPS of $0.60. The company announced a definitive agreement to acquire SFE Group and repurchased approximately $15 million in stock. Gross margin expanded to 53.0%, driven by tariff refunds and organic growth, particularly from Cortland Biomedical.

Enerpac Tool Group reported third-quarter fiscal 2026 results with net sales of $167.6 million, a 6% year-over-year increase and $29.8 million in net earnings ($0.58 diluted EPS). Adjusted diluted EPS was $0.60 for the quarter and adjusted EBITDA reached $46.9 million, reflecting margin expansion. The company also announced a definitive agreement to acquire SFE Group and repurchased roughly $15 million of stock in the quarter.

Financial Highlights

  • Revenue: Net sales of $167.6 million for the three months ended May 31, 2026 (6% increase vs. prior year; 3% organic growth).
  • Gross profit and margin: Gross profit of $88.8 million; gross margin of 53.0% (up 260 basis points year over year, including expected IEEPA tariff refund benefit).
  • Operating income: Operating profit of $41.4 million for the quarter.
  • Net income and EPS: Net earnings of $29.8 million; diluted EPS of $0.58 for the quarter.
  • Adjusted results: Adjusted diluted EPS of $0.60 and adjusted EBITDA of $46.9 million (adjusted EBITDA margin 28.0%).

Business Highlights

  • Segment performance: Industrial Tool & Service (IT&S) product sales increased 5% organically year over year while IT&S service revenue declined 8% organically; service revenue improved 17% sequentially.
  • Growth drivers: Cortland Biomedical delivered 25% year-over-year growth in the quarter, contributing to consolidated organic sales growth.
  • Capital allocation: Returned approximately $15 million to shareholders via repurchases (about 420,000 shares); $120 million remains available under the $200 million authorization.
  • Acquisition activity: Signed a definitive agreement to acquire Specialized Fabrication Equipment (SFE) Group to expand complementary product offerings and reach in higher-growth markets and geographies.
  • Cash generation and liquidity: Year-to-date cash provided by operations of $69.3 million; cash balance of $115.7 million and net debt to adjusted EBITDA of 0.5x as of May 31, 2026.

Original SEC Filing: ENERPAC TOOL GROUP CORP [ EPAC ] - 8-K - Jul. 08, 2026

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Login to unlock1,718characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Enerpac Tool

Enerpac Tool

EPAC.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--